Quarterly report pursuant to Section 13 or 15(d)

Net Loss Per Share (Details) - Schedule of potential common shares

v3.22.2
Net Loss Per Share (Details) - Schedule of potential common shares - shares
 6 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Total common stock equivalents 133,326,635 170,017,583
Conversion of Convertible Preferred Stock [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Total common stock equivalents [1] 28,693,931 116,264,374
Warrants to Purchase Common Stock and Redeemable Convertible Preferred Stock [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Total common stock equivalents [1] 25,599,889 14,738,710
PSUs, RSUs and Options to Purchase Common Stock [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Total common stock equivalents [1] 61,532,815 39,014,499
Right to Receive Earnout Shares [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Total common stock equivalents 17,500,000  
[1] Prior period results have been adjusted to reflect the exchange of Legacy MoneyLion Common Stock for MoneyLion Class A Common Stock at the Exchange Ratio of approximately 16.4078 in September 2021 as a result of the Business Combination. See Note 3, “Business Combination” for details.